These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28951668)

  • 1. Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery.
    Tong GF; Qin N; Sun LW
    Saudi Pharm J; 2017 Sep; 25(6):844-851. PubMed ID: 28951668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Neuroprotective Effect of Thymoquinone Nanoformulation in the Rodent Cerebral Ischemia-Reperfusion Model.
    Xiao XY; Zhu YX; Bu JY; Li GW; Zhou JH; Zhou SP
    Biomed Res Int; 2016; 2016():2571060. PubMed ID: 27725936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal bilosomes in thermosensitive hydrogel: advancing desvenlafaxine succinate delivery for depression management.
    El-Nawawy TM; Adel YA; Teaima M; Nassar NN; Nemr AA; Al-Samadi I; El-Nabarawi MA; Elhabal SF
    Pharm Dev Technol; 2024 Sep; 29(7):663-674. PubMed ID: 38965754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
    Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
    J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nano-in-Micro-Particles Consisting of PLGA Nanoparticles Embedded in Chitosan Microparticles via Spray-Drying Enhances Their Uptake in the Olfactory Mucosa.
    Spindler LM; Feuerhake A; Ladel S; Günday C; Flamm J; Günday-Türeli N; Türeli E; Tovar GEM; Schindowski K; Gruber-Traub C
    Front Pharmacol; 2021; 12():732954. PubMed ID: 34539414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification and Evaluations of Catechin Hydrate Polymeric Nanoparticles Used in Brain Targeting for the Treatment of Epilepsy.
    Ahmad N; Ahmad R; Alrasheed RA; Almatar HMA; Al-Ramadan AS; Amir M; Sarafroz M
    Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32120778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulating chitosan-PLGA nanoparticle properties to design a co-delivery platform for glioblastoma therapy intended for nose-to-brain route.
    Ferreira NN; Granja S; Boni FI; Prezotti FG; Ferreira LMB; Cury BSF; Reis RM; Baltazar F; Gremião MPD
    Drug Deliv Transl Res; 2020 Dec; 10(6):1729-1747. PubMed ID: 32683647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
    Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
    Pandit J; Sultana Y; Aqil M
    Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced sustained release of furosemide in long circulating chitosan-conjugated PLGA nanoparticles.
    Kashyap S; Singh A; Mishra A; Singh V
    Res Pharm Sci; 2019 Apr; 14(2):93-106. PubMed ID: 31620185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
    Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
    Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.
    Elsaid N; Jackson TL; Elsaid Z; Alqathama A; Somavarapu S
    Mol Pharm; 2016 Sep; 13(9):2923-40. PubMed ID: 27286558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain targeted delivery of carmustine using chitosan coated nanoparticles via nasal route for glioblastoma treatment.
    Ahmad S; Khan I; Pandit J; Emad NA; Bano S; Dar KI; Rizvi MMA; Ansari MD; Aqil M; Sultana Y
    Int J Biol Macromol; 2022 Nov; 221():435-445. PubMed ID: 36067850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
    Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
    Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice.
    Sunena ; Singh SK; Mishra DN
    Curr Drug Deliv; 2019; 16(1):51-58. PubMed ID: 30289074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
    Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
    Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of bleomycin-induced pulmonary fibrosis by inhaled tacrolimus-loaded chitosan-coated poly(lactic-co-glycolic acid) nanoparticles.
    Lee C; Seo J; Hwang HS; Thao LQ; Lee S; Lee ES; Lee EH; Choi HG; Youn YS
    Biomed Pharmacother; 2016 Mar; 78():226-233. PubMed ID: 26898446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
    ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.